For instance, in breast, lung, colorectal and ovarian cancers, high G9a expression were associated with shorter overall survival in patients and the depletion of G9a suppressed several cancer hallmarks such as proliferation, invasiveness and tumour maintenance [13, 14, 18, 42]. This evidence concerns the gene EHMT2 and ovarian cancer.